share_log

HC Wainwright & Co. Maintains Buy on Biotricity, Lowers Price Target to $2

HC Wainwright & Co. Maintains Buy on Biotricity, Lowers Price Target to $2

HC Wainwright & Co.維持對Biotricity的買入,將目標價下調至2美元
Benzinga Real-time News ·  2022/07/15 06:24

HC Wainwright & Co. analyst Kevin Dede maintains Biotricity (NASDAQ:BTCY) with a Buy and lowers the price target from $6 to $2.

HC Wainwright & Co. 分析師凱文·德德維持Biotricity(納斯達克股票代碼:BTCY)的買入並將目標股價從6美元下調至2美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論